Western Wealth Management LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Western Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,636 shares of the financial services provider’s stock, valued at approximately $225,000.

Several other large investors also recently added to or reduced their stakes in the business. Crewe Advisors LLC grew its position in iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares during the period. Apexium Financial LP boosted its position in shares of iShares Biotechnology ETF by 3.8% in the fourth quarter. Apexium Financial LP now owns 2,223 shares of the financial services provider’s stock worth $302,000 after purchasing an additional 82 shares during the period. Perkins Coie Trust Co boosted its position in shares of iShares Biotechnology ETF by 0.3% in the second quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock worth $3,457,000 after purchasing an additional 83 shares during the period. Optimum Investment Advisors boosted its position in shares of iShares Biotechnology ETF by 2.9% in the second quarter. Optimum Investment Advisors now owns 3,024 shares of the financial services provider’s stock worth $415,000 after purchasing an additional 85 shares during the period. Finally, Penbrook Management LLC boosted its position in shares of iShares Biotechnology ETF by 2.3% in the first quarter. Penbrook Management LLC now owns 4,050 shares of the financial services provider’s stock worth $556,000 after purchasing an additional 90 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB traded up $1.55 during mid-day trading on Monday, reaching $146.40. The stock had a trading volume of 268,834 shares, compared to its average volume of 1,583,444. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.17. The business has a fifty day moving average of $141.14 and a 200 day moving average of $136.77.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.